MedTrace Logo

Wide-field Optical Coherence Tomography Imaging of Excised Breast Tissue.

NCT04242277 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 198

Last updated 2023-05-19

No results posted yet for this study

Summary

This is a single-arm, multi-center data collection study designed to collect WF-OCT imaging data of excised breast tissue margins with corresponding margin status from histopathology.

Conditions

  • Breast Cancer Female

Interventions

DEVICE

Investigational WF-OCT device

Excised lumpectomy tissue will be imaged on an investigational WF-OCT device

Sponsors & Collaborators

  • Cancer Prevention Research Institute of Texas

    collaborator OTHER

  • Perimeter Medical Imaging

    lead INDUSTRY

Principal Investigators

  • Savitri Krishnamurthy, MD · M.D. Anderson Cancer Center

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-03
Primary Completion
2021-07-27
Completion
2021-07-27
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04242277 on ClinicalTrials.gov